Mesfin Gewe

634 total citations · 1 hit paper
10 papers, 379 citations indexed

About

Mesfin Gewe is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Mesfin Gewe has authored 10 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Immunology. Recurrent topics in Mesfin Gewe's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Chemical Synthesis and Analysis (2 papers) and HIV Research and Treatment (2 papers). Mesfin Gewe is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Chemical Synthesis and Analysis (2 papers) and HIV Research and Treatment (2 papers). Mesfin Gewe collaborates with scholars based in United States and South Africa. Mesfin Gewe's co-authors include Roland K. Strong, David Baker, Colin Correnti, Mi‐Youn Brusniak, James M. Olson, Della Friend, Suzie H. Pun, Vishaka Muhunthan, Matthew J. Bick and Stanley R. Riddell and has published in prestigious journals such as Science, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Mesfin Gewe

10 papers receiving 376 citations

Hit Papers

Designed protein logic to target cells with precise combi... 2020 2026 2022 2024 2020 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mesfin Gewe United States 8 217 104 90 78 60 10 379
Sandrine Vessillier United Kingdom 12 198 0.9× 175 1.7× 120 1.3× 74 0.9× 70 1.2× 29 475
Chien‐Hsun Wu Taiwan 6 357 1.6× 64 0.6× 49 0.5× 154 2.0× 97 1.6× 7 529
Tilda Barliya Israel 10 185 0.9× 133 1.3× 159 1.8× 40 0.5× 63 1.1× 18 432
Eric Voltà‐Durán Spain 13 301 1.4× 54 0.5× 78 0.9× 89 1.1× 58 1.0× 33 467
Dong-Ki Choi South Korea 10 280 1.3× 107 1.0× 81 0.9× 159 2.0× 15 0.3× 17 406
Joong‐jae Lee South Korea 13 367 1.7× 103 1.0× 88 1.0× 198 2.5× 60 1.0× 31 547
Rita Sala Spain 11 230 1.1× 79 0.8× 132 1.5× 66 0.8× 34 0.6× 15 371
Hassan Dana Iran 9 571 2.6× 136 1.3× 100 1.1× 26 0.3× 87 1.4× 18 797
Anne‐Marie Ray United States 11 276 1.3× 101 1.0× 50 0.6× 31 0.4× 31 0.5× 18 442
Amber Downes Ireland 4 278 1.3× 48 0.5× 131 1.5× 48 0.6× 78 1.3× 7 465

Countries citing papers authored by Mesfin Gewe

Since Specialization
Citations

This map shows the geographic impact of Mesfin Gewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mesfin Gewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mesfin Gewe more than expected).

Fields of papers citing papers by Mesfin Gewe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mesfin Gewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mesfin Gewe. The network helps show where Mesfin Gewe may publish in the future.

Co-authorship network of co-authors of Mesfin Gewe

This figure shows the co-authorship network connecting the top 25 collaborators of Mesfin Gewe. A scholar is included among the top collaborators of Mesfin Gewe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mesfin Gewe. Mesfin Gewe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Crook, Zachary R., Emily J. Girard, Mi‐Youn Brusniak, et al.. (2022). Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager. Science Translational Medicine. 14(645). eabn0402–eabn0402. 7 indexed citations
2.
Doyle, Lindsey, Betty Shen, Mesfin Gewe, et al.. (2021). Design of functionalised circular tandem repeat proteins with longer repeat topologies and enhanced subunit contact surfaces. Communications Biology. 4(1). 1240–1240. 5 indexed citations
3.
Lajoie, Marc J., Scott E. Boyken, Alexander I. Salter, et al.. (2020). Designed protein logic to target cells with precise combinations of surface antigens. Science. 369(6511). 1637–1643. 144 indexed citations breakdown →
4.
Girard, Emily J., Gene Hopping, Fiona Pakiam, et al.. (2020). A potent peptide-steroid conjugate accumulates in cartilage and reverses arthritis without evidence of systemic corticosteroid exposure. Science Translational Medicine. 12(533). 32 indexed citations
5.
DeBuysscher, Blair L., Connor Weidle, Abigail Wall, et al.. (2019). Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes. The Journal of Experimental Medicine. 216(10). 2331–2347. 18 indexed citations
6.
Correnti, Colin, Mesfin Gewe, Christopher Mehlin, et al.. (2018). Screening, large-scale production and structure-based classification of cystine-dense peptides. Nature Structural & Molecular Biology. 25(3). 270–278. 48 indexed citations
7.
Crook, Zachary R., Della Friend, Mi‐Youn Brusniak, et al.. (2017). Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets. Nature Communications. 8(1). 2244–2244. 65 indexed citations
8.
Cai, Xin, Mesfin Gewe, Isaac Jenkins, et al.. (2017). Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells. Neoplasia. 19(6). 471–482. 22 indexed citations
9.
Rosinski, Steven Lawrence, Rainer Storb, Roland K. Strong, et al.. (2015). Anti-CD28 Antibody-Initiated Cytokine Storm in Canines. Transplantation Direct. 1(2). 1–11. 20 indexed citations
10.
Finton, Kathryn A. K., Della Friend, Mesfin Gewe, et al.. (2014). Ontogeny of Recognition Specificity and Functionality for the Broadly Neutralizing Anti-HIV Antibody 4E10. PLoS Pathogens. 10(9). e1004403–e1004403. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026